Referenced Data for Parents Concerning the Pfizer COVID-19 Vaccination for Children Aged 5 through 11 Years
Journal of American Physicians and Surgeons | Winter 2021 On Oct 29, 2021, the Food and Drug Association (FDA) extended its Emergency Use Authorization (EUA) for the PfizerBioNTech “vaccine” to be given to reduce serious COVID-19 infections in children aged 5 through 11 years. The FDA provided little evidence for its decision except for a…